10 facts about the newest preventive migraine therapy

Neurologist explains why this drug class is winning the pain war

This content has been independently produced by ADG, made possible through sponsorship from Eli Lilly.

migraine vice

About a third of people with migraine would benefit from preventive treatment yet only a small proportion of those are receiving this therapy, and even then, discontinuation rates tend to be high, research shows.

The main reason for this discrepancy is that oral